On August 28, prescription drug coupon company GoodRx filed for an IPO, with the company citing their strong record of profitability as the reason for going public.
The startup is planning to raise up to $100 million in the IPO, according to S-1 documents filed with the U.S. Securities and Exchange Commission. The Santa-Monica based company, which was founded in 2011, stated that its stock will be traded on NASDAQ under GDRX.
Soaring Popularity and Profits
In 2016, GoodRx was valued at $2.8 billion when technology private equity firm Silver Lake invested in it, and has been profitable on and off since 2013. The company is popular and sought out by consumers. Approximately 17 million Americans view the site every month in hopes of securing lower prices for their prescription drug…